Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine W Tai, L He, X Zhang, J Pu, D Voronin, S Jiang, Y Zhou, L Du Cellular & molecular immunology 17 (6), 613-620, 2020 | 1969 | 2020 |
A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2 W Tai, X Zhang, A Drelich, J Shi, JC Hsu, L Luchsinger, CD Hillyer, ... Cell research 30 (10), 932-935, 2020 | 159 | 2020 |
Neutralizing antibodies for the prevention and treatment of COVID-19 XZ Lanying Du, Yang Yang Cell Mol Immunol 10 (2293-2306), 2021 | 131* | 2021 |
Identification of SARS-CoV RBD-targeting Monoclonal Antibodies With Cross-Reactive or Neutralizing Activity Against SARS-CoV-2. LD Wanbo Tai,Xiujuan Zhang, Yuxian He, Shibo Jiang Antiviral Research, 2020 | 127 | 2020 |
Neutralizing antibodies for the treatment of COVID-19 S Jiang, X Zhang, Y Yang, PJ Hotez, L Du Nature biomedical engineering 4 (12), 1134-1139, 2020 | 104 | 2020 |
Enfuvirtide (T20)-based lipopeptide is a potent HIV-1 cell fusion inhibitor: implications for viral entry and inhibition X Ding, X Zhang, H Chong, Y Zhu, H Wei, X Wu, J He, X Wang, Y He Journal of virology 91 (18), 10.1128/jvi. 00831-17, 2017 | 97 | 2017 |
Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection PLOS PATHOGENS 1009897, 2021 | 75 | 2021 |
A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses L Du, VHC Leung, X Zhang, J Zhou, M Chen, W He, HY Zhang, ... PloS one 6 (1), e16555, 2011 | 60 | 2011 |
Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2 S Jiang, X Zhang, L Du Expert opinion on therapeutic targets 25 (6), 415-421, 2021 | 58 | 2021 |
Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies L Du, G Zhao, X Zhang, Z Liu, H Yu, BJ Zheng, Y Zhou, S Jiang Biochemical and biophysical research communications 397 (3), 580-585, 2010 | 47 | 2010 |
A Critical HA1 Neutralizing Domain of H5N1 Influenza in an Optimal Conformation Induces Strong Cross- Protection SJ Lanying Du 1. , Guangyu Zhao 2. , Shihui Sun 2 , Xiujuan Zhang 1 ... PLOS ONE 8 (1), e53568, 2013 | 38 | 2013 |
Structural and functional characterization of HIV-1 cell fusion inhibitor T20 X Zhang, X Ding, Y Zhu, H Chong, S Cui, J He, X Wang, Y He Aids 33 (1), 1-11, 2019 | 37 | 2019 |
Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies FL Lanying Du, Yang Yang, Xiujuan Zhang Nanoscale, 2022 | 34 | 2022 |
A built-in CpG adjuvant in RSV F protein DNA vaccine drives a Th1 polarized and enhanced protective immune response Y Ma, YY Jiao, YZ Yu, N Jiang, Y Hua, XJ Zhang, YH Fu, XL Peng, ... Viruses 10 (1), 38, 2018 | 32 | 2018 |
Advances in mRNA and other vaccines against MERS-CoV LD Wanbo Tai 1, Xiujuan Zhang 1, Yang Yang 2, Jiang Zhu 3 Transl Res. 7, 2021 | 31* | 2021 |
Exceptional potency and structural basis of a T1249-derived lipopeptide fusion inhibitor against HIV-1, HIV-2, and simian immunodeficiency virus Y Zhu, X Zhang, X Ding, H Chong, S Cui, J He, X Wang, Y He Journal of Biological Chemistry 293 (14), 5323-5334, 2018 | 29 | 2018 |
Maleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission L Li, P Qiao, J Yang, L Lu, S Tan, H Lu, X Zhang, X Chen, S Wu, S Jiang, ... Retrovirology 7, 1-18, 2010 | 29 | 2010 |
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection LD Juan Shi # 1 2, Jian Zheng # 3, Wanbo Tai # 2, Abhishek K Verma 3 ... J Virol 96 (17), 2022 | 27 | 2022 |
A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus YY Jiao, YH Fu, YF Yan, Y Hua, Y Ma, XJ Zhang, JD Song, XL Peng, ... Antiviral research 144, 57-69, 2017 | 22 | 2017 |
RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge LDU JUAN SHI , JIAN ZHENG , XIUJUAN ZHANG, WANBO TAI, ABBY E. ODLE, STANLEY ... Translational Research, 2022 | 20 | 2022 |